Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review.
Study Design
- Tipo de estudio
- Cohort
- Tamaño de muestra
- 66
- Intervención
- Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review. None
- Comparador
- Placebo
- Dirección del efecto
- Positive
- Riesgo de sesgo
- High
Abstract
The prevalence of telogen effluvium (TE) has increased during COVID-19. In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2019
Comorbidities in alopecia areata: A systematic review and meta-analysis.
American journal of clinical dermatology · 2018
Vitamin D and the Skin: An Update for Dermatologists.
Skin pharmacology and physiology · 2013
Serum ferritin and vitamin d in female hair loss: do they play a role?
American journal of clinical dermatology · 2017
The Role of Micronutrients in Alopecia Areata: A Review.
The Journal of clinical endocrinology and metabolism · 2019
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
Experimental dermatology · 2017